Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Holstege CP, Borek HA. Toxidromes. Crit Care Clin. 2012;28(4):479–98. https://doi.org/10.1016/j.ccc.2012.07.008.
2. Rasimas JJ, Sinclair CM. Assessment and management of toxidromes in the critical care unit. Crit Care Clin. 2017;33(3):521–41. https://doi.org/10.1016/j.ccc.2017.03.002.
3. Farmer B, Seger DL. Poisoning: overview of approaches for evaluation and treatment. In: Vincent JL, Abraham E, Moore FA, Kochanek P, Fink MP, editors. Textbook of critical care, seventh edition. Philadelphia: Elsevier; 2017. p. 1070–5.
4. Schneir AB, Offerman SR, Ly BT, Davis JM, Baldwin RT, Williams SR, et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med. 2003;42(1):14–9. https://doi.org/10.1067/mem.2003.232.
5. Boley SP, Olives TD, Bangh SA, Fahrner S, Cole JB. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center. Clin Toxicol (Phila). 2019;57(1):50–5. https://doi.org/10.1080/15563650.2018.1485154A prospective study showing the efficacy and safety profile of using physostigmine in anticholinergic toxicity.